Global Bovine Tuberculosis Diagnosis Market Size study, by Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests) and Regional Forecasts 2022-2028

Global Bovine Tuberculosis Diagnosis Market Size study, by Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests) and Regional Forecasts 2022-2028

Global Bovine Tuberculosis Diagnosis Market is valued approximately USD 707.4 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.2 % over the forecast period 2022-2028. Mycobacterium bovis causes bovine tuberculosis (bTB). Bovine TB is most common in Africa, and while it mostly affects cattle, it also affects other domestic animals such as sheep, goats, pigs, and dogs. Increasing cattle population, expanding consumption of animal products, developing zoonotic concerns, initiatives undertaken by important firms, and supporting legislation and programmes adopted by governments are some of the key drivers driving market growth. For example, in 1917, the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) launched the National Tuberculosis Eradication Program with the goal of eliminating bovine tuberculosis in the United States. Among other activities, the programme includes ongoing and periodic testing of cattle across the country to identify tuberculosis. This is expected to help the industry flourish. Increased bovine TB eradication and surveillance activities by governments, R&D investments by key firms, post-pandemic return to normal, and growth of test kinds and service offerings are some of the main forces fueling the market for bovine TB diagnostics. In June 2019, the World Organization for Animal Health (OIE) authorised Enferplex Bovine TB Antibody test, which was made in Ireland by Enfer Group. This test kit assists in the identification of M. bovis antibodies in cow serum samples, and is thus recommended by the OIE for serological infection diagnosis and management. To expand its distribution channel, the firm teamed with Sure Farm Ltd to market its goods throughout the United Kingdom. These favourable aspects contributed to the expansion of the market for bovine tuberculosis diagnosis throughout the forecast period. However, lack of awareness will stymie market expansion throughout the projection period of 2022-2028.

The key regions considered for the Global Bovine Tuberculosis Diagnosis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe emerged as the market leader. The existence of significant businesses, the implementation of numerous strategic measures to improve market penetration, growing government programmes for bovine TB eradication, and a big cow population all contribute to the European region's high share. According to the European Commission, the region's bovine population was predicted to be more over 77 million in December 2019. Asia Pacific gained a significant revenue share and is expected to expand at the quickest CAGR. This is due to expanding illness awareness in emerging nations and rising disposable income in major markets. The rising demand for effective and timely diagnosis of bovine tuberculosis in countries such as India is fueling the expansion of the market for bovine tuberculosis diagnosis.

Major market player included in this report are:

IDEXX Laboratories, Inc.
PBD Biotech Ltd.
Zoetis
IDvet
Thermo Fisher Scientific Inc.
Enfer Group
AsureQuality Australia Pty Ltd.
Bio-Rad Laboratories, Inc.
Bionote
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test Type:
Serological Tests
Molecular Diagnostic Tests
Traditional Tests
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Bovine Tuberculosis Diagnosis Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

IDEXX Laboratories, Inc.
PBD Biotech Ltd.
Zoetis
IDvet
Thermo Fisher Scientific Inc.
Enfer Group
AsureQuality Australia Pty Ltd.
Bio-Rad Laboratories, Inc.
Bionote

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.